What do systematic reviews say?

Aromatherapy vs placebo or usual care

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupressure vs placebo or control

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 459 participants
  Low

Exercise vs control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupressure vs placebo or control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupressure vs placebo or control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupressure vs placebo or control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupressure vs placebo or control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Acupressure vs placebo or control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise vs control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise vs control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise vs control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise vs control

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Aromatherapy vs placebo or usual care

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 542 participants
  Low

Aromatherapy vs placebo or usual care

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Aromatherapy vs placebo or usual care

The review found no eligible studies for this question.

• Interventions for fatigue in people with kidney failure requiring dialysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

DPP‐4 inhibitors vs sulphonylureas

It is very uncertain whether DPP‐4 inhibitors changes hypoglycaemic episodes a) Non‐serious hypoglycaemia compared with sulphonylureas (very low certainty).

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  RR 0.53 [0.41, 0.68]
  4 studies · 2495 participants
  Very low

Meglitinides vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Meglitinides vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Meglitinides vs sulphonylureas

The review found no eligible studies for this question.

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Meglitinides vs sulphonylureas

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 235 participants
  Very low